Aripiprazole in Adolescents With Schizophrenia

Completed · Phase 3 · Has a placebo group

Conditions studied: Schizophrenia

In brief

The purpose of this trial is to test the safety and efficacy of aripiprazole in adolescent patients with schizophrenia for a period of at least 6 weeks.

Key facts

Study ID
NCT00102063
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
302
Starts
2004-07-01
Expected to finish
2006-08-01
Last updated by the study team
2012-08-10

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.